Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Bernstein

Showing results (251-260 of 698) with videos related to

Pageof 70
Sort By:
Annals of Medicine and Surgery (2012)|January 18, 2022
Contact dermatitis due to personal protective equipment use and hygiene practices during the COVID-19 pandemic: A systematic review of case reportsZouina Sarfraz, Azza Sarfraz, Muzna Sarfraz, et al.
American Journal of Rhinology & Allergy|October 8, 2009
Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitisJonathan A Bernstein, Bruce Prenner, Berrylin J Ferguson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 16, 2020
A novel functional C1 inhibitor activity assay in dried blood spot for diagnosis of Hereditary angioedemaYongquan Lai, Guodong Zhang, Zhiwei Zhou, et al.
Allergy and Asthma Proceedings|May 17, 2013
Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedemaCheng Gang, Christopher J Lindsell, Joseph Moellman, et al.
Dermatology and Therapy|September 30, 2023
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current StatusThomas B Casale, Ana Maria Gimenez-Arnau, Jonathan A Bernstein, et al.
International Archives of Allergy and Immunology|August 9, 2017
A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air ProvocationUmesh Singh, Jonathan A Bernstein, Holly Lorentz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 13, 2009
Is exhaled nitric oxide a useful adjunctive test for assessing asthma?Jonathan A Bernstein, Ben Davis, María J Alvarez-Puebla, et al.
Immunotherapy|April 7, 2025
A plain language summary of a review about omalizumab for people with chronic spontaneous urticariaThomas B Casale, Ana Maria Gimenez-Arnau, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 21, 2024
Patient-Reported Outcome Measures in Chronic Spontaneous Urticaria, Angioedema, and Atopic DermatitisJonathan A Bernstein, Chistian Apfelbacher, Derek K Chu, et al.
Current Medical Research and Opinion|May 13, 2024
Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice surveyArpamas Seetasith, Michael Holden, James Hetherington, et al.
Pageof 70

Showing results (251-260 of 698) with videos related to

Sort By:
Pageof 70
Annals of Medicine and Surgery (2012)|January 18, 2022
Contact dermatitis due to personal protective equipment use and hygiene practices during the COVID-19 pandemic: A systematic review of case reportsZouina Sarfraz, Azza Sarfraz, Muzna Sarfraz, et al.
American Journal of Rhinology & Allergy|October 8, 2009
Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitisJonathan A Bernstein, Bruce Prenner, Berrylin J Ferguson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 16, 2020
A novel functional C1 inhibitor activity assay in dried blood spot for diagnosis of Hereditary angioedemaYongquan Lai, Guodong Zhang, Zhiwei Zhou, et al.
Allergy and Asthma Proceedings|May 17, 2013
Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedemaCheng Gang, Christopher J Lindsell, Joseph Moellman, et al.
Dermatology and Therapy|September 30, 2023
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current StatusThomas B Casale, Ana Maria Gimenez-Arnau, Jonathan A Bernstein, et al.
International Archives of Allergy and Immunology|August 9, 2017
A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air ProvocationUmesh Singh, Jonathan A Bernstein, Holly Lorentz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 13, 2009
Is exhaled nitric oxide a useful adjunctive test for assessing asthma?Jonathan A Bernstein, Ben Davis, María J Alvarez-Puebla, et al.
Immunotherapy|April 7, 2025
A plain language summary of a review about omalizumab for people with chronic spontaneous urticariaThomas B Casale, Ana Maria Gimenez-Arnau, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 21, 2024
Patient-Reported Outcome Measures in Chronic Spontaneous Urticaria, Angioedema, and Atopic DermatitisJonathan A Bernstein, Chistian Apfelbacher, Derek K Chu, et al.
Current Medical Research and Opinion|May 13, 2024
Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice surveyArpamas Seetasith, Michael Holden, James Hetherington, et al.
Pageof 70